The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice

Author(s):
Landlinger, C.; Pouwer, M.G.; Juno, C.; Hoorn, J.W.A. van der; Pieterman, E.J.; Jukema, J.W. (0000-0002-3246-8359); Staffler, G.; Princen, H.M.G.; Galabova, G.
Published
2017
Publication type
Article / Letter to editor
AtherosclerosisAnti-PCSK9 vaccineAPOE*3Leiden.CETP miceSystemic and vascular inflammation
Date issued
2017-08-21
Language
English
Is part of
European Heart Journal (2017), Vol. 38, no. 32, p. 2499-U143
hdl
1887/95103
doi
10.1093/eurheartj/ehx260